Literature DB >> 34963323

Supercharged End-to-Side Anterior Interosseous to Ulnar Motor Nerve Transfer for Hirayama Disease: A Case Report.

Aleixo Abreu Tanure1, Luis Guilherme Rosifini Alves Rezende2, Ana Carolina Pazim1, Marcel Leal Ribeiro1.   

Abstract

Hirayama disease is a rare condition of cervical myelopathy. Its early identification and correction can optimize functional outcomes. However, late presentation and some more severe cases may be associated with loss of hand function. Among the cases described, there are no reports of nerve transfers for this condition. We presented the first case report of a Hirayama disease of isolated ulnar nerve impairment managed with nerve transfer. Electroneuromyography showed isolated preganglionic involvement of C7, C8, and T1, with no sensory changes. The patient underwent nerve transfer with anterior interosseous nerve to ulnar nerve supercharge end-to-side, recovering hand function in 7 months.

Entities:  

Keywords:  Hirayama disease; nerve transfer; spinal cord compression

Mesh:

Year:  2021        PMID: 34963323      PMCID: PMC9274879          DOI: 10.1177/15589447211063556

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  8 in total

Review 1.  Hirayama disease.

Authors:  Emma Foster; Benjamin K-T Tsang; Anthony Kam; Elsdon Storey; Bruce Day; Aron Hill
Journal:  J Clin Neurosci       Date:  2015-03-09       Impact factor: 1.961

2.  Hirayama disease: a frequently undiagnosed condition with simple inexpensive treatment.

Authors:  Rajesh Verma; Rakesh Lalla; Tushar B Patil; Arvind Gupta
Journal:  BMJ Case Rep       Date:  2012-12-06

Review 3.  Juvenile muscular atrophy of distal upper extremity (Hirayama disease).

Authors:  K Hirayama
Journal:  Intern Med       Date:  2000-04       Impact factor: 1.271

4.  Supercharged end-to-side anterior interosseous to ulnar motor nerve transfer for intrinsic musculature reinnervation.

Authors:  John Barbour; Andrew Yee; Lorna C Kahn; Susan E Mackinnon
Journal:  J Hand Surg Am       Date:  2012-10       Impact factor: 2.230

5.  A clinical study of Hirayama disease in Taiwan.

Authors:  Ying-Chih Huang; Long-Sun Ro; Hong-Shiu Chang; Chiung-Mei Chen; Yih-Ru Wu; Jian-Der Lee; Rong-Kuo Lyu
Journal:  Muscle Nerve       Date:  2008-05       Impact factor: 3.217

6.  Hirayama disease: Is surgery an option?

Authors:  M Agundez; I Rouco; J Barcena; B Mateos; J Barredo; J J Zarranz
Journal:  Neurologia       Date:  2013-08-20       Impact factor: 3.109

7.  Advanced Hirayama disease with successful improvement of activities of daily living by operative reconstruction.

Authors:  Susumu Chiba; Kazumi Yonekura; Michio Nonaka; Tomihiro Imai; Hiroyuki Matumoto; Takuro Wada
Journal:  Intern Med       Date:  2004-01       Impact factor: 1.271

8.  Clinical and radiological profile of Hirayama disease: A flexion myelopathy due to tight cervical dural canal amenable to collar therapy.

Authors:  K M Hassan; Hirdesh Sahni; Atul Jha
Journal:  Ann Indian Acad Neurol       Date:  2012-04       Impact factor: 1.383

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.